PRESS RELEASE published on 08/16/2023 at 08:15, 1 year 3 months ago EXASOL AG: Exasol publishes half-year report and confirms preliminary figures
PRESS RELEASE published on 08/08/2023 at 09:34, 1 year 3 months ago Exasol publishes preliminary figures for the first half of 2023, outlook confirmed
PRESS RELEASE published on 06/30/2023 at 09:01, 1 year 4 months ago EXASOL SUCCESSFULLY COMPLETES CAPITAL INCREASE AND GENERATES GROSS PROCEEDS OF 7.1 MILLION EUROS
PRESS RELEASE published on 06/30/2023 at 08:49, 1 year 4 months ago EQS-Adhoc: EXASOL SUCCESSFULLY PLACES 2.4 MILLION NEW SHARES FROM CASH CAPITAL INCREASE WITH GROSS PROCEEDS OF EUR 7.1 MILLION
PRESS RELEASE published on 06/29/2023 at 17:45, 1 year 4 months ago EQS-Adhoc: EXASOL AG: EXASOL LAUNCHES 10% CASH CAPITAL INCREASE, TARGETING GROSS PROCEEDS OF APPROXIMATELY EUR 7 MILLION
PRESS RELEASE published on 05/30/2023 at 11:11, 1 year 5 months ago Exasol Unveils the No-Compromise Analytics Database Unlocking Greater Productivity, Cost-Savings, and Flexibility
PRESS RELEASE published on 05/10/2023 at 08:29, 1 year 6 months ago Exasol publishes audited consolidated financial statements for 2022 and earnings for Q1 2023
PRESS RELEASE published on 04/28/2023 at 08:01, 1 year 6 months ago Exasol announces preliminary figures for first quarter 2023: Operating profit improves - new business in the U.S. market ramps up
PRESS RELEASE published on 02/17/2023 at 13:07, 1 year 9 months ago EXASOL AG: Exasol announces preliminary figures for 2022, outlook for 2023 and need to adjust the 2025 mid-term target
PRESS RELEASE published on 02/17/2023 at 12:51, 1 year 9 months ago EQS-Adhoc: EXASOL AG: Exasol announces preliminary figures for 2022, outlook for 2023 and the need to adjust the 2025 mid-term target
Published on 11/21/2024 at 13:30, 22 minutes ago AirIQ Announces September 30, 2024 Quarterly Results Company Reports Double-Digit Growth in Recurring Revenue
Published on 11/21/2024 at 13:30, 22 minutes ago Datametrex Secures Additional P.O. Approx $250K for IT Services
Published on 11/21/2024 at 13:00, 52 minutes ago Aclara Secures Funding from Corfo's Innovation High-Tech Program for Artificial Intelligence Project
Published on 11/21/2024 at 13:00, 52 minutes ago Telomir Pharmaceuticals Confirms Age Reversal, Increased Longevity and Improved Healthspan in Groundbreaking Preclinical Study with Telomir-1
Published on 11/21/2024 at 13:00, 52 minutes ago Toggle3D.ai Rebrands as FOTOgpt.ai to Usher in a New Age of AI-Powered Photography
Published on 11/21/2024 at 12:35, 1 hour 17 minutes ago audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 12:15, 1 hour 37 minutes ago Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Published on 11/21/2024 at 06:58, 6 hours 54 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 18 hours 32 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 20 hours 7 minutes ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 20 hours 7 minutes ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 6 hours ago Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo
